Putnam Global Health Care A (PHSTX)
Fund Assets | 1.38B |
Expense Ratio | 1.05% |
Min. Investment | $500 |
Turnover | 36.00% |
Dividend (ttm) | 2.74 |
Dividend Yield | 4.53% |
Dividend Growth | -15.55% |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 23, 2024 |
Previous Close | 56.64 |
YTD Return | 2.31% |
1-Year Return | -12.00% |
5-Year Return | 38.59% |
52-Week Low | 52.11 |
52-Week High | 68.97 |
Beta (5Y) | 0.59 |
Holdings | 91 |
Inception Date | May 28, 1982 |
About PHSTX
Putnam Global Health Care Fund Class A is an actively managed mutual fund focused on achieving capital appreciation by investing primarily in common stocks of large and midsize companies within the global healthcare sector. The fund leverages deep fundamental research and technical analysis to identify opportunities, particularly emphasizing scientific innovation and evolving regulatory landscapes. Its approach includes a concentrated portfolio, typically holding 40-50 high-conviction positions, allowing for meaningful exposure to its top choices. Major holdings often include prominent healthcare firms such as Eli Lilly, UnitedHealth Group, AbbVie, and AstraZeneca, among others, reflecting a broad yet targeted exposure to biopharmaceuticals, medical devices, and healthcare services. The fund’s strategy provides investors with access to a diverse range of companies driving innovation in health sciences worldwide, making it a significant vehicle for those seeking participation in the ongoing advancements and structural growth of the global healthcare industry.
Performance
PHSTX had a total return of -12.00% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.64%.
Top 10 Holdings
52.96% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 10.17% |
AbbVie Inc. | ABBV | 6.51% |
Johnson & Johnson | JNJ | 6.20% |
AstraZeneca PLC | AZN | 5.26% |
Thermo Fisher Scientific Inc. | TMO | 4.80% |
Boston Scientific Corporation | BSX | 4.39% |
Abbott Laboratories | ABT | 4.21% |
Novartis AG | NOVN | 4.18% |
Merck & Co., Inc. | MRK | 3.94% |
UnitedHealth Group Incorporated | UNH | 3.30% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 23, 2024 | $2.742 | Dec 26, 2024 |
Dec 21, 2023 | $3.247 | Dec 26, 2023 |
Dec 22, 2022 | $4.460 | Dec 27, 2022 |
Dec 22, 2021 | $7.599 | Dec 27, 2021 |
Dec 23, 2020 | $5.707 | Dec 28, 2020 |
Dec 23, 2019 | $3.227 | Dec 26, 2019 |